Synergistic antibacterial and antibiofilm effect between (+)-medioresinol and antibiotics in vitro

Applied Biochemistry and Biotechnology

Volumn 170, Issue 8, 2013, Pages 1934-1941

  Hwang, Ji Hong ^a   Choi, Hyemin ^a   Hwang, In Sok ^a   Kim, A Ryun ^b   Woo, Eun Rhan ^b   Lee, Dong Gun ^a  

^a Kyungpook National University   (South Korea)

^b Chosun University   (South Korea)

Author keywords

(+) Medioresinol; Antibacterial activity; Antibiofilm effect; Antibiotic resistance; Synergistic effect

Indexed keywords

(+)-MEDIORESINOL; ANTI-BACTERIAL ACTIVITY; ANTI-BIOFILM; ANTIBIOTIC RESISTANCE; SYNERGISTIC EFFECT;

BIOCHEMISTRY;

ANTIBIOTICS;

AMPICILLIN; ANTIBIOTIC AGENT; CEFOTAXIME; CHLORAMPHENICOL; MEDIORESINOL; UNCLASSIFIED DRUG;

ANTIBIOTIC RESISTANCE; ANTIBIOTIC SENSITIVITY; ANTIMICROBIAL ACTIVITY; ARTICLE; BACTERIAL STRAIN; BIOFILM; CONTROLLED STUDY; IN VITRO STUDY; PSEUDOMONAS AERUGINOSA; SAMBUCUS; SAMBUCUS WILLIAMSII;

ANTI-BACTERIAL AGENTS; BIOFILMS; CELL SURVIVAL; DRUG SYNERGISM; LIGNANS; PSEUDOMONAS AERUGINOSA; SAMBUCUS;

EID: 84881279581     PISSN: 02732289     EISSN: 15590291     Source Type: Journal    
DOI: 10.1007/s12010-013-0351-7     Document Type: Article

References (31)

1. Mesaros, N.; Nordmann, P.; Plesiat, P.; Van Roussel-Delvallez, M.; Eldere, J.; Glupczynski, Y. V.; et al. (2007). Clinical Microbiology and Infection, 13, 560-5787. (Pubitemid 46730662)
2. Nishanth Kumar, S.; Siji, J. V.; Nambisan, B.; Mohandas, C. (2012). World Journal of Microbiology and Biotechnology, 28, 3143-3150.
3. Beringer, P. M. (1999). Current Opinion in Pulmonary Medicine, 5, 371-377.
4. Chung, P. Y.; Parasakthi, N.; Chung, L. Y. (2011). Annals of Clinical Microbiology and Antimicrobials, 10, 1-6.
5. Lee, Y.; Jang, K.; Cha, J. (2012). Journal of Biomedicine and Biotechnology, 618081, 1-7.
6. Hoiby, N.; Bjarnsholt, T.; Givskov, M.; Molin, S.; Ciofu, O. (2010). International Journal of Antimicrobial Agents, 35, 322-332.
7. Lynch, S. V.; Dixon, L.; Benoit, M. R.; Brodie, E. L.; Keyhan, M.; Hu, P.; et al. (2007). Antimicrobial Agents and Chemotherapy, 51, 3650-3658. (Pubitemid 47519356)
8. Liaqat, I.; Sabri, A. N. (2008). Journal of Basic Microbiology, 49, 1-10.
9. Boyer, J.; Liu, R. H. (2004). Nutrition Journal, 3, 5.
10. Zakay-Rones, Z.; Varsano, N.; Zlotnik, M.; Manor, O.; Regev, L.; Schlesinger, M.; et al. (1995). Journal of Alternative and Complementary Medicine, 1, 361-369.
11. Ahmadiani, A.; Fereidoni, M.; Semnanian, S.; Kamalinejad, M.; Saremi, S. (1998). Journal of Ethnopharmacology, 61, 229-235. (Pubitemid 28342690)
12. Xie, F.; Wu, C. F.; Zhang, Y.; Yao, X. S.; Cheung, P. Y.; Chan, A. S.; Wong, M. S. (2005). Biological and Pharmaceutical Bulletin, 28, 1879-1885. (Pubitemid 41437074)
13. Yan, Z. H.; Yang, C. H.; Wu, X. H.; Xie, Y. Y. (2004). Chinese Chemical Letters, 15, 408-410.
14. Hwang, J. H.; Hwang, I. S.; Liu, Q. H.; Woo, E. R.; Lee, D. G. (2012). Biochimie, 94, 1784-1793.
15. Li, C. Y.; Li, Y. C. (1999). Acta Pharmaceutica Sinica, 34, 605-607.
16. Zhou, L. X.; Dind, Y. (2000). Zhongguo Zhong Yao Za Zhi, 25, 541-543.
17. CLSI. (2005). Performance standards for antimicrobial susceptibility testing. Wayne: CLSI.
18. Eliopoulos, G. M.; Moellering, R. C. (1991). Antimicrobial combinations. In V. Lorian (Ed.), Antibiotics in laboratory medicine (pp. 432-492). Baltimore: Williams & Wilkins.
19. NCCLS. (2003) Methods for dilution antimicrobial susceptibility tests for bacteria that grow aerobically. National committee for clinical Laboratory Standards USA M7-A6.
20. Pankey, G. A.; Ashcraft, D. S. (2005). Antimicrobial Agents and Chemotherapy, 49, 2959-2964. (Pubitemid 40917617)
21. Odds, F. C. (2003). Journal of Antimicrobial Chemotherapy, 52, 1.
22. Christensen, G. D.; Simpson, W. A.; Younger, J. J.; Baddour, L. M.; Barrett, F. F.; Melton, D. M.; et al. (1985). Journal of Clinical Microbiology, 22, 996-1006.
23. Wei, G. X.; Campagna, A. N.; Bobek, L. A. (2006). Journal of Antimicrobial Chemotherapy, 57, 1100-1109. (Pubitemid 44644411)
24. Kohanski, M. A.; Dwyer, D. J.; Collins, J. J. (2010). Nature Reviews Microbiology, 8, 423-435.
25. William, F.; Marshall, M. D.; Janis, E.; Blair, M. D. (1999). Mayo Clinic Proceedings, 74, 187-195.
26. An, J.; Zuo, G. Y.; Haob, X. Y.; Wanga, G. C.; Li, Z. S. (2011). Phytomedicine, 18, 990-993.
27. Gradelski, E.; Valera, L.; Bonner, D.; Fung-Tomc, J. (2001). Antimicrobial Agents and Chemotherapy, 45, 3220-3222. (Pubitemid 32988856)
28. White, R. L.; Burgess, D. S.; Manduru, M.; Bosso, J. A. (1996). Antimicrobial Agents and Chemotherapy, 40, 1914-1918.
29. Mushtaq, S.; Ge, Y.; Livermore, D. M. (2004). Antimicrobial Agents and Chemotherapy, 48, 3086-3092. (Pubitemid 38989178)
30. Hancock, R. E. (1985). Antibiotics and Chemotherapy, 36, 95-102.
31. Buyck, J. M.; Plésiat, P.; Traore, H.; Vanderbist, F.; Van Tulkens, P. M.; Bambeke, F. (2012). Clinical Infectious Diseases, 55, 534-542.